AU2016315648B2 - Probes for imaging huntingtin protein - Google Patents

Probes for imaging huntingtin protein Download PDF

Info

Publication number
AU2016315648B2
AU2016315648B2 AU2016315648A AU2016315648A AU2016315648B2 AU 2016315648 B2 AU2016315648 B2 AU 2016315648B2 AU 2016315648 A AU2016315648 A AU 2016315648A AU 2016315648 A AU2016315648 A AU 2016315648A AU 2016315648 B2 AU2016315648 B2 AU 2016315648B2
Authority
AU
Australia
Prior art keywords
carboxamide
thia
dodeca
methoxy
pentaene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2016315648A
Other languages
English (en)
Other versions
AU2016315648A1 (en
Inventor
Jonathan Bard
Christopher John Brown
Daniel CLARK-FREW
Samuel COE
Celia Dominguez
Samantha Louise Jones GREEN
Sarah HAYES
Duane HIGGINS
Peter David Johnson
Thomas Martin Krulle
Richard Waldron Marston
Matthew Robert MILLS
Michael Edward PRIME
John Wityak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHDI Foundation
Original Assignee
CHDI Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHDI Foundation filed Critical CHDI Foundation
Publication of AU2016315648A1 publication Critical patent/AU2016315648A1/en
Application granted granted Critical
Publication of AU2016315648B2 publication Critical patent/AU2016315648B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/002—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nuclear Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2016315648A 2015-08-28 2016-08-26 Probes for imaging huntingtin protein Active AU2016315648B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562211118P 2015-08-28 2015-08-28
US62/211,118 2015-08-28
PCT/US2016/049112 WO2017040336A1 (en) 2015-08-28 2016-08-26 Probes for imaging huntingtin protein

Publications (2)

Publication Number Publication Date
AU2016315648A1 AU2016315648A1 (en) 2018-03-29
AU2016315648B2 true AU2016315648B2 (en) 2021-04-01

Family

ID=58103449

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2016315648A Active AU2016315648B2 (en) 2015-08-28 2016-08-26 Probes for imaging huntingtin protein

Country Status (18)

Country Link
US (3) US10137211B2 (enExample)
EP (1) EP3340796B1 (enExample)
JP (1) JP6944929B2 (enExample)
CN (1) CN108135172B (enExample)
AU (1) AU2016315648B2 (enExample)
BR (1) BR112018003331B1 (enExample)
CA (1) CA2995847C (enExample)
DK (1) DK3340796T3 (enExample)
ES (1) ES2885053T3 (enExample)
HR (1) HRP20211156T1 (enExample)
HU (1) HUE056509T2 (enExample)
IL (1) IL257537B (enExample)
MX (1) MX382156B (enExample)
PL (1) PL3340796T3 (enExample)
PT (1) PT3340796T (enExample)
RU (1) RU2721419C2 (enExample)
SI (1) SI3340796T1 (enExample)
WO (1) WO2017040336A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20211778T1 (hr) 2014-08-29 2022-03-18 Chdi Foundation, Inc. Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina
SG11201701578YA (en) 2014-08-29 2017-03-30 Chdi Foundation Inc Probes for imaging huntingtin protein
SG11201701580XA (en) 2014-08-29 2017-03-30 Chdi Foundation Inc Probes for imaging huntingtin protein
PL3197277T3 (pl) 2014-08-29 2022-04-04 Chdi Foundation, Inc. Sondy do obrazowania molekularnego białka huntingtyny
CA2995847C (en) 2015-08-28 2024-05-28 Chdi Foundation, Inc. Probes for imaging huntingtin protein
WO2019157128A1 (en) 2018-02-08 2019-08-15 Phraxis Inc. End to end anastomotic connector
EP3749225A4 (en) * 2018-02-08 2021-11-17 Phraxis Inc. ONE-PIECE ANASTOMOTIC CONNECTOR
WO2020176424A1 (en) 2019-02-25 2020-09-03 Chdi Foundation, Inc. Compounds for targeting mutant huntingtin protein and uses thereof
IL298941A (en) * 2020-06-11 2023-02-01 Chdi Foundation Inc Heterocyclic compounds and imaging agents for the imaging of huntingtin protein
MX2023011888A (es) * 2021-04-08 2023-12-06 Chdi Foundation Inc Compuestos de isoindolinona y agentes de formación de imágenes para la obtencion de imágenes de la proteína huntingtina.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100098634A1 (en) * 2008-07-24 2010-04-22 Kolb Hartmuth C Imaging Agents Useful for Identifying AD Pathology
US20120070374A1 (en) * 2009-02-11 2012-03-22 Henriksen Gjermund Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2126636T3 (es) 1992-05-19 1999-04-01 Adir Derivados del bencimidazol con actividad antidiabetica y antiagregante plaquetaria.
JP2000351782A (ja) * 1999-04-06 2000-12-19 Yamanouchi Pharmaceut Co Ltd メタボトロピックグルタメート受容体作用薬及び新規チアゾロベンゾイミダゾール誘導体
AU2241400A (en) * 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
UY27003A1 (es) 2000-11-06 2002-07-31 Schering Ag Productos radiofarmacéuticos para el diagnóstico de la enfermedad de alzheimer
WO2005048953A2 (en) * 2003-11-13 2005-06-02 Ambit Biosciences Corporation Amide derivatives as kinase modulators
TW201018678A (en) * 2006-01-27 2010-05-16 Astrazeneca Ab Novel heteroaryl substituted benzothiazoles
FR2919610B1 (fr) * 2007-08-02 2009-10-16 Sanofi Aventis Sa Derives de n-heteroaryl-carboxamides tricycliques,leur preparation et leur application en therapeutique
CN102438660A (zh) 2009-03-23 2012-05-02 美国西门子医疗解决公司 用于检测神经障碍的显像剂
HK1210732A1 (en) 2012-07-11 2016-05-06 Nimbus Iris, Inc. Irak inhibitors and uses thereof
US9902702B2 (en) * 2014-07-15 2018-02-27 Bristol-Myers Squibb Company Spirocycloheptanes as inhibitors of rock
PL3197277T3 (pl) 2014-08-29 2022-04-04 Chdi Foundation, Inc. Sondy do obrazowania molekularnego białka huntingtyny
HRP20211778T1 (hr) 2014-08-29 2022-03-18 Chdi Foundation, Inc. Kontrastna sredstva za slikovnu dijagnostiku huntingtin proteina
SG11201701580XA (en) 2014-08-29 2017-03-30 Chdi Foundation Inc Probes for imaging huntingtin protein
SG11201701578YA (en) 2014-08-29 2017-03-30 Chdi Foundation Inc Probes for imaging huntingtin protein
CA2995847C (en) 2015-08-28 2024-05-28 Chdi Foundation, Inc. Probes for imaging huntingtin protein

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100098634A1 (en) * 2008-07-24 2010-04-22 Kolb Hartmuth C Imaging Agents Useful for Identifying AD Pathology
US20120070374A1 (en) * 2009-02-11 2012-03-22 Henriksen Gjermund Compounds for Non-Invasive Measurement of Aggregates of Amyloid Peptides

Also Published As

Publication number Publication date
MX2018002338A (es) 2018-07-06
DK3340796T3 (da) 2021-07-26
US10137211B2 (en) 2018-11-27
US10765764B2 (en) 2020-09-08
US20210060187A1 (en) 2021-03-04
PT3340796T (pt) 2021-07-28
CA2995847C (en) 2024-05-28
IL257537B (en) 2020-08-31
RU2721419C2 (ru) 2020-05-19
HRP20211156T1 (hr) 2021-12-24
HUE056509T2 (hu) 2022-02-28
RU2018110055A3 (enExample) 2019-10-28
JP6944929B2 (ja) 2021-10-06
US20190167821A1 (en) 2019-06-06
MX382156B (es) 2025-03-13
CN108135172B (zh) 2021-03-30
AU2016315648A1 (en) 2018-03-29
EP3340796A4 (en) 2019-05-15
RU2018110055A (ru) 2019-09-30
US11344637B2 (en) 2022-05-31
PL3340796T4 (pl) 2022-02-21
CA2995847A1 (en) 2017-03-09
CN108135172A (zh) 2018-06-08
US20170056535A1 (en) 2017-03-02
SI3340796T1 (sl) 2022-02-28
PL3340796T3 (pl) 2022-02-21
EP3340796B1 (en) 2021-04-21
WO2017040336A1 (en) 2017-03-09
ES2885053T3 (es) 2021-12-13
EP3340796A1 (en) 2018-07-04
JP2018531897A (ja) 2018-11-01
IL257537A (en) 2018-04-30
BR112018003331B1 (pt) 2022-05-10
BR112018003331A2 (pt) 2018-11-06

Similar Documents

Publication Publication Date Title
US11344637B2 (en) Probes for imaging huntingtin protein
US12036291B2 (en) Probes for imaging huntingtin protein
US11851446B2 (en) Probes for imaging Huntingtin protein
WO2016033445A1 (en) Probes for imaging huntingtin protein
US10907197B2 (en) Probes for imaging huntingtin protein
HK1257113A1 (en) Probes for imaging huntingtin protein
HK1257113B (en) Probes for imaging huntingtin protein
HK1241224B (en) Probes for imaging huntingtin protein
HK1240582B (en) Probes for imaging huntington protein
HK1240582A1 (en) Probes for imaging huntington protein

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)